• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾特发性肺纤维化的一项基于人群的研究。

Idiopathic pulmonary fibrosis in Taiwan - a population-based study.

机构信息

Department of Intensive Care Medicine, Chi Mei Medical Center, Liouying, Tainan, Taiwan.

出版信息

Respir Med. 2012 Nov;106(11):1566-74. doi: 10.1016/j.rmed.2012.07.012. Epub 2012 Sep 4.

DOI:10.1016/j.rmed.2012.07.012
PMID:22954482
Abstract

BACKGROUND

This study took advantage of a large population-based database of the Taiwan National Health Insurance (NHI) to investigate the epidemiology of idiopathic pulmonary fibrosis (IPF) in Taiwan.

METHODS

This is a retrospective cohort study based on secondary analysis of prospectively collected data in the NHI system and governmental data on death registry in Taiwan during 1997-2007. By using the broad and narrow definitions for IPF, we estimated incidence and prevalence rates of IPF, and its associated clinical outcomes.

RESULTS

The estimates of annual IPF incidence rates became more stable after 2000, ranging between 0.9 and 1.6 cases per 100,000 persons. The prevalence rates became more than twofold from 2000 to 2007 (from 2.8 to 6.4 cases per 100,000 persons for the broad definition, and from 2.0 to 4.9 cases per 100,000 persons for the narrow definition). Men of age older than 75 years had markedly higher incidence and prevalence rates than other groups. Around 40% of all incidences and about 30% of prevalent cases occurred in this population group. The median survival time after IPF diagnosis was 0.9 year (interquartile range (IQR), 0.2-2.5 years) and 0.7 year (IQR, 0.1-2.3 years) for the broad and narrow definitions, respectively. Progression of IPF was the leading cause of death, followed by cancer.

CONCLUSIONS

In Taiwan, elderly men were the major group suffering from IPF. Survival time was short after IPF diagnosis, and the poor survival was largely attributable to quick IPF progression after diagnosis.

摘要

背景

本研究利用台湾全民健康保险(NHI)的大型基于人群的数据库,调查了台湾特发性肺纤维化(IPF)的流行病学情况。

方法

这是一项基于回顾性队列研究,对 NHI 系统中前瞻性收集的数据和台湾政府关于 1997-2007 年死亡登记的数据进行二次分析。通过使用 IPF 的广义和狭义定义,我们估算了 IPF 的发病率和患病率,并评估了其相关的临床结局。

结果

2000 年后,IPF 的年发病率估计值变得更加稳定,范围在每 10 万人中 0.9 至 1.6 例之间。2000 年至 2007 年,患病率增加了一倍以上(广义定义下从每 10 万人 2.8 例增加到 6.4 例,狭义定义下从每 10 万人 2.0 例增加到 4.9 例)。年龄大于 75 岁的男性发病率和患病率明显高于其他人群。所有发病的 40%左右和约 30%的现患病例发生在该人群中。IPF 诊断后中位生存时间为 0.9 年(四分位间距(IQR),0.2-2.5 年)和 0.7 年(IQR,0.1-2.3 年),分别用于广义和狭义定义。IPF 的进展是死亡的主要原因,其次是癌症。

结论

在台湾,老年男性是患 IPF 的主要人群。IPF 诊断后生存时间较短,诊断后 IPF 迅速进展是生存不良的主要原因。

相似文献

1
Idiopathic pulmonary fibrosis in Taiwan - a population-based study.台湾特发性肺纤维化的一项基于人群的研究。
Respir Med. 2012 Nov;106(11):1566-74. doi: 10.1016/j.rmed.2012.07.012. Epub 2012 Sep 4.
2
Idiopathic Pulmonary Fibrosis (IPF) incidence and prevalence in Italy.意大利特发性肺纤维化(IPF)的发病率和患病率。
Sarcoidosis Vasc Diffuse Lung Dis. 2014 Oct 20;31(3):191-7.
3
Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada.加拿大全国数据中特发性肺纤维化的流行病学和生存情况。
Eur Respir J. 2016 Jul;48(1):187-95. doi: 10.1183/13993003.01504-2015. Epub 2016 May 26.
4
Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm Validation.美国自动索赔中的特发性肺纤维化。发病率、患病率和算法验证。
Am J Respir Crit Care Med. 2015 Nov 15;192(10):1200-7. doi: 10.1164/rccm.201504-0818OC.
5
Epidemiologic Analysis of Taiwanese Patients with Idiopathic Pulmonary Fibrosis.台湾特发性肺纤维化患者的流行病学分析
Healthcare (Basel). 2020 Dec 21;8(4):580. doi: 10.3390/healthcare8040580.
6
Idiopathic pulmonary fibrosis in a referral center in Iran: are patients developing the disease at a younger age?伊朗转诊中心的特发性肺纤维化:患者发病年龄是否更小?
Arch Iran Med. 2013 Mar;16(3):177-81.
7
Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan.台湾系统性硬化症的流行病学和死亡率:一项全国性人群研究。
Scand J Rheumatol. 2011;40(5):373-8. doi: 10.3109/03009742.2011.553736. Epub 2011 Mar 9.
8
Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11.美国 65 岁及以上医疗保险受益人群中的特发性肺纤维化:2001-2011 年的发病率、患病率和生存率。
Lancet Respir Med. 2014 Jul;2(7):566-72. doi: 10.1016/S2213-2600(14)70101-8. Epub 2014 May 27.
9
Incidence and prevalence of idiopathic interstitial pneumonia and idiopathic pulmonary fibrosis in Korea.韩国特发性间质性肺炎和特发性肺纤维化的发病率及患病率。
Int J Tuberc Lung Dis. 2016 Jul;20(7):978-84. doi: 10.5588/ijtld.16.0003.
10
[A retrospective cohort study of prognostic factors for death in patients with idiopathic pulmonary fibrosis].[特发性肺纤维化患者死亡预后因素的回顾性队列研究]
Zhonghua Jie He He Hu Xi Za Zhi. 2010 Dec;33(12):887-91.

引用本文的文献

1
Incidence and prevalence of idiopathic pulmonary fibrosis: a systematic literature review and meta-analysis.特发性肺纤维化的发病率和患病率:一项系统文献综述与荟萃分析。
BMC Pulm Med. 2025 Aug 7;25(1):378. doi: 10.1186/s12890-025-03836-1.
2
Shifting Trends in the Epidemiology and Management of Idiopathic Pulmonary Fibrosis in the Era of Evidence-Based Guidelines: a Nationwide Population Study.循证指南时代特发性肺纤维化流行病学和管理的变化趋势:一项全国性人群研究
J Epidemiol Glob Health. 2025 Mar 17;15(1):44. doi: 10.1007/s44197-025-00377-y.
3
Epidemiology of idiopathic pulmonary fibrosis in central and Western Pennsylvania.
宾夕法尼亚州中部和西部特发性肺纤维化的流行病学
Respir Res. 2025 Mar 10;26(1):97. doi: 10.1186/s12931-025-03164-2.
4
The Accuracy of Japanese Administrative Data in Identifying Acute Exacerbation of Idiopathic Pulmonary Fibrosis.日本行政数据在识别特发性肺纤维化急性加重方面的准确性
Ann Clin Epidemiol. 2022 Feb 9;4(2):53-62. doi: 10.37737/ace.22008. eCollection 2022.
5
Prevalence, incidence, and survival analysis of interstitial lung diseases in Hong Kong: a 16-year population-based cohort study.香港间质性肺疾病的患病率、发病率及生存分析:一项基于人群的16年队列研究。
Lancet Reg Health West Pac. 2023 Aug 10;42:100871. doi: 10.1016/j.lanwpc.2023.100871. eCollection 2024 Jan.
6
Real-world practice of idiopathic pulmonary fibrosis: Results from a 2000-2016 cohort.特发性肺纤维化的真实世界实践:2000 - 2016年队列研究结果
Open Med (Wars). 2023 Nov 11;18(1):20230852. doi: 10.1515/med-2023-0852. eCollection 2023.
7
Nationwide epidemiologic study for fibrosing interstitial lung disease (F-ILD) in South Korea: a population-based study.韩国全国性纤维化性间质性肺病(F-ILD)的流行病学研究:一项基于人群的研究。
BMC Pulm Med. 2023 Mar 22;23(1):98. doi: 10.1186/s12890-023-02373-z.
8
Deficiency of HtrA3 Attenuates Bleomycin-Induced Pulmonary Fibrosis Via TGF-β1/Smad Signaling Pathway.HtrA3 缺乏通过 TGF-β1/Smad 信号通路减轻博来霉素诱导的肺纤维化。
Lung. 2023 Apr;201(2):235-242. doi: 10.1007/s00408-023-00608-8. Epub 2023 Feb 24.
9
External validation of the GAP model in Chinese patients with idiopathic pulmonary fibrosis.中文特发性肺纤维化患者 GAP 模型的外部验证。
Clin Respir J. 2023 Sep;17(9):831-840. doi: 10.1111/crj.13564. Epub 2022 Nov 27.
10
NICEFIT-A Prospective, Non-Interventional, and Multicentric Study for the Management of Idiopathic Pulmonary Fibrosis with Antifibrotic Therapy in Taiwan.NICEFIT-A:台湾地区特发性肺纤维化抗纤维化治疗管理的前瞻性、非干预性多中心研究
Biomedicines. 2022 Sep 22;10(10):2362. doi: 10.3390/biomedicines10102362.